Clinical Trials Browser

urelumab × Dermatologic × Clear all

NCT02652455 2025-08-19

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

Phase EARLY_PHASE1 Completed

Melanoma, Skin Neoplasms

NCT00612664 2015-10-12

Phase II, 2nd Line Melanoma - RAND Monotherapy

Phase 2 Completed

Melanoma

NCT00803374 2011-11-21

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Phase 1 Withdrawn

Melanoma